Bio for Robert Shapiro, M.D., Ph.D. Robert Shapiro, M.D., Ph.D.ProfessorDepartment of Neurological Sciences Contact Information E-mail: Robert.Shapiro@uvm.eduPhone: Clinic (802) 847-4589Office Location: Department of Neurology, 1 South Prospect St. - Arnold 2435D, Burlington, VT 05401 Education1987: Columbia University, New York, NY. Doctor of Medicine.1985: University of Oxford, Oxford, England. Master of Arts in Philosophy/Psychology.1984: University of Pennsylvania, Philadelphia, PA. PhD in Anatomy.1980: University of Oxford, Oxford, England. Bachelor of Arts in Philosophy/Psychology with honors.1978: University of Pennsylvania, Philadelphia, PA. Master of Arts in Biology.1978: University of Pennsylvania, Philadelphia, PA. Bachelor of Arts in Biology. cum laude.Awards and Honors2013: American Academy of Neurology, Kenneth M. Viste, Jr., MD, Patient Advocate of the Year Award2013: Headache Cooperative of New England, Lifetime Achievement ('Megrim') Award2013: Fellow, American Academy of Neurology2012: American Headache Society, Harold G. Wolff Lecture Award2008-2012: Founding President, Alliance For Headache Disorders Advocacy2007: American Academy of Neurology, Palatucci Advocate of the Year Award2003-2005: Frymoyer Scholar, College of Medicine, University of Vermont2002-2008: President, Headache Cooperative of New England2002: Migraine Innovators Merit Award, AstraZeneca Pharmaceuticals 1996: Solo Cup Clinician Scientist Award, Johns Hopkins School of Medicine 1991-1996: NIH / NINDS [K08], Clinical Investigator Development Award1991: Merck Clinician Scientist Award, Johns Hopkins School of Medicine 1987: The Helen M. Sciarra Prize in Neurology, Columbia University 1980-1981: University Fellowship, University of Pennsylvania1978-1980: Thouron Award, University of Oxford, England PublicationsBrennan KC, Bates EA, Shapiro RE, Zyuzin J, Hallows WC, Huang Y, Lee HY, Jones CR, Fu YH, Charles AC, Ptácek LJ. Casein kinase id mutations in familial migraine and advanced sleep phase. Sci Transl Med. 5:183ra56 (2013).Shapiro RE. Lagniappe: the impact of headache disorders in America. Headache. 53:196-204 (2013).Schürks, M., P.M. Rist, R.E. Shapiro, T. Kurth. Migraine and Mortality: A systematic review and meta-analysis. Cephalalgia. 31:1301-14 (2011).Evans, R.W., S.J. Tepper, R.E. Shapiro, C. Sun-Edelstein, & G.E. Tietjen. The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society Position Paper Headache 50:1089-1099 (2010).Connor KM, Shapiro RE, Diener HC, Lucas S, Kost J, Fan X, Fei K, Assaid C, Lines C, Ho TW. Randomized, controlled trial of telcagepant for the acute treatment of migraine. Neurology 73:970-7 (2009).Xu Y, Padiath QS, Shapiro RE, Jones CR, Wu SC, Saigoh N, Saigoh K, Ptácek LJ, Fu YH. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome. Nature. 434:640-4 (2005).Paznekas WA, Boyadjiev SA, Shapiro RE, Daniels O, Wollnik B, Keegan CE, Innis JW, Dinulos MB, Christian C, Hannibal MC, Jabs EW. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. Am J Hum Genet. 72:408-18. (2003).To view more of Dr. Shapiro's publications, please visit PubMed.